AI-Powered Fast and Cost-Effective Antibody De Novo Design and Affinity Maturation Service Unveiled

Revolutionary AI Technology Transforms Antibody Development and Optimization Ainnocence, a leading AI innovator in biotechnology launched a groundbreaking AI-enabled platform for antibody affinity maturation and de novo design. This powerful animal free platform, driven by Ainnocence’s proprietary SentinusAI® protein generative AI engine, is set to revolutionize the field of antibody discovery and optimization by replacing tradition…